Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Current data on tiagabine].

¹Servicio de Neuropediatría, Hospital Universitario Marqués de Valdecilla, Santander, España. med003087@nacom.es

Revista De Neurologia

|July 25, 2000

Summary

Tiagabine (TGB) effectively treats partial seizures by enhancing GABAergic inhibition. It demonstrates good tolerance, particularly when initiated gradually, making it a valuable option for difficult-to-control epilepsy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Antiepileptic drugs].

Revista de neurologia·2018

Same author

[Rufinamide. A review of its pharmacokinetic and pharmacodynamic properties].

Revista de neurologia·2008

Same author

[Rational combination therapy in epilepsy. III. Possible associations between antiepileptic drugs].

Revista de neurologia·2007

Same author

[Rational combination therapy in epilepsy. II. Clinical and pharmacological aspects].

Revista de neurologia·2007

Same author

[Rational combination therapy in epilepsy. I. Concepts and foundations].

Revista de neurologia·2007

Same author

[Cognitive repercussion of early-onset epilepsies].

Revista de neurologia·2007

Area of Science:

Pharmacology
Neurology
Clinical Medicine

Background:

Tiagabine (TGB) is an antiepileptic drug.
It functions by blocking the reuptake of gamma-aminobutyric acid (GABA).
This action enhances inhibitory neurotransmission in the central nervous system.

Purpose of the Study:

To review current data on tiagabine (TGB).
Focus on its mechanism of action, pharmacokinetics, clinical effectiveness, and safety profile.
Evaluate its role in epilepsy management.

Main Methods:

Literature review of clinical trials and studies on TGB.
Analysis of data concerning efficacy and tolerance.
Comparison with other antiepileptic drugs like lamotrigine and topiramate.

Main Results:

TGB demonstrates an antiepileptic effect in patients of all ages with partial seizures.
The drug exhibits good tolerance, especially with slow introduction over eight weeks.
Efficacy and tolerance data from clinical trials support its use.

Conclusions:

Tiagabine (TGB) is an effective and well-tolerated treatment for difficult-to-control partial seizures.
Further research is warranted to define its efficacy and tolerance in less severe or previously untreated seizure cases.
Consideration for use in broader patient populations is suggested.

Related Experiment Videos